A graduate of the Feinberg School of Medicine at Northwestern University in Chicago, Dr. Bobby Buka is New York's leading dermatologist who
treats tens of thousands of patients every year.
Not exact matches
While a new generation
of safer, more effective oral medications to
treat hepatitis C
patients may cost
tens of thousands of dollars for a 12 - week regiment, investing in these new therapies could generate savings estimated at more than $ 3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week ® (DDW) 2015.
«Our outcomes data already show this approach effectively
treats and cures disease, in addition to saving
patients tens of thousands of dollars in unnecessary medical spending.»